During the past decade, Vidant Oncology-Kinston conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 59 clinical trials were completed, i.e. on average, 103.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 35 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vidant Oncology-Kinston" #1 sponsor was "National Cancer Institute (NCI)" with 85 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "GOG Foundation" with 7 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vidant Oncology-Kinston" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Vidant Oncology-Kinston" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials), "Stage IIIB Breast Cancer AJCC v7" (7 trials), "Stage IIIC Breast Cancer AJCC v7" (7 trials) and "Clear Cell Renal Cell Carcinoma" (6 trials). Many other conditions were trialed in "Vidant Oncology-Kinston" in a lesser frequency.

Most popular intervention types in "Vidant Oncology-Kinston" are "Drug" (99 trials), "Other" (87 trials), "Biological" (57 trials), "Procedure" (30 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Quality-of-Life Assessment" (42 trials), "Computed Tomography" (19 trials), "Biospecimen Collection" (18 trials) and "Paclitaxel" (16 trials). Other intervention names were less common.

The vast majority of trials in "Vidant Oncology-Kinston" are 99 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vidant Oncology-Kinston". undefined are not yet recruiting, 22 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Vidant Oncology-Kinston, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vidant Oncology-Kinston, 2 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Vidant Oncology-Kinston has several departments that took part in Clinical trials: "Vidant Oncology-Kenansville" - 45 trials